Ophthalmology

The CGTLive™ Ophthalmology specialty topic page includes the most recent clinical care news related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for disorders and diseases of the eye. It also contains video interviews with key opinion leaders in the field of ophthalmology discussing related FDA actions, clinical guideline updates, and clinical trial findings in the field of gene and cell therapy for ophthalmic conditions.

Latest News

Around the Helix: Cell and Gene Therapy Company Updates – July 16, 2025

Around the Helix: Cell and Gene Therapy Company Updates – July 16, 2025

By Noah Stansfield

July 16th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Nanoscope Therapeutics Puts Rolling BLA for Retinitis Pigmentosa Gene Therapy MCO-010 in Front of FDA

Nanoscope Therapeutics Puts Rolling BLA for Retinitis Pigmentosa Gene Therapy MCO-010 in Front of FDA

By Noah Stansfield

July 15th 2025

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – July 11, 2025

By Noah Stansfield

July 11th 2025

Around the Helix: Cell and Gene Therapy Company Updates – July 9, 2025

Around the Helix: Cell and Gene Therapy Company Updates – July 9, 2025

By Noah Stansfield

July 9th 2025

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – July 4, 2025

By Noah Stansfield

July 4th 2025

Video Interviews

Podcasts

ImmunoLogic Episode 4

ImmunoLogic

ImmunoLogic

ImmunoLogic

ImmunoLogic

Latest CME Events & Activities

(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

More News

Around the Helix: Cell and Gene Therapy Company Updates – July 2, 2025

Around the Helix: Cell and Gene Therapy Company Updates – July 2, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Data Roundup: June 2025 Features Updates from EHA, ASCO, and More

Data Roundup: June 2025 Features Updates from EHA, ASCO, and More

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

FDA Activity Recap: June 2025 Features New Platform Designation, IND Clearance, and More

FDA Activity Recap: June 2025 Features New Platform Designation, IND Clearance, and More

Noah Stansfield

Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – June 27, 2025

Noah Stansfield

Review top news and interview highlights from the week ending June 27, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – June 25, 2025

Around the Helix: Cell and Gene Therapy Company Updates – June 25, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – June 20, 2025

Noah Stansfield

Review top news and interview highlights from the week ending June 20, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – June 18, 2025

Around the Helix: Cell and Gene Therapy Company Updates – June 18, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – June 13, 2025

Noah Stansfield

Review top news and interview highlights from the week ending June 13, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – June 11, 2025

Around the Helix: Cell and Gene Therapy Company Updates – June 11, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Data Roundup: May 2025 Features Updates from ASGCT, ASCO, and More

Data Roundup: May 2025 Features Updates from ASGCT, ASCO, and More

Noah Stansfield

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – June 6, 2025

Noah Stansfield

Review top news and interview highlights from the week ending June 6, 2025.

FDA Activity Recap: May 2025 Features BLA Acceptance in MPS II, AdComm Announcement for DMD Cell Therapy, and More

FDA Activity Recap: May 2025 Features BLA Acceptance in MPS II, AdComm Announcement for DMD Cell Therapy, and More

Noah Stansfield

Catch up on any of the key FDA news stories you may have missed last month, with coverage highlights from the CGTLive® team.

Around the Helix: Cell and Gene Therapy Company Updates – June 4, 2025

Around the Helix: Cell and Gene Therapy Company Updates – June 4, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – May 30, 2025

Noah Stansfield

Review top news and interview highlights from the week ending May 30, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – May 28, 2025

Around the Helix: Cell and Gene Therapy Company Updates – May 28, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Ocugen’s Gene Therapy OCU410ST Nets Rare Pediatric Disease Designation for ABCA4-Associated Retinopathies

Ocugen’s Gene Therapy OCU410ST Nets Rare Pediatric Disease Designation for ABCA4-Associated Retinopathies

Noah Stansfield

Alongside the announcement, Ocugen noted that it intends to initiate a phase 2/3 confirmatory clinical trial for OCU410ST in the coming weeks.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – May 23, 2025

Noah Stansfield

Review top news and interview highlights from the week ending May 23, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – May 21, 2025

Around the Helix: Cell and Gene Therapy Company Updates – May 21, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – May 16, 2025

Noah Stansfield

Review top news and interview highlights from the week ending May 16, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – May 14, 2025

Around the Helix: Cell and Gene Therapy Company Updates – May 14, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – May 9, 2025

Noah Stansfield

Review top news and interview highlights from the week ending May 9, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – May 7, 2025

Around the Helix: Cell and Gene Therapy Company Updates – May 7, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

J&J's XLRP Gene Therapy Bota-Vec Falls Short of Primary End Points

J&J's XLRP Gene Therapy Bota-Vec Falls Short of Primary End Points

J&J purchased the full rights to bota-vec in a 2023 deal with MeiraGTx

Neurophth is Tackling LHON-ND4 With Gene Therapy NR082 in Phase 1/2/3 GOLD Trial

Neurophth is Tackling LHON-ND4 With Gene Therapy NR082 in Phase 1/2/3 GOLD Trial

Noah Stansfield

For Healthy Vision Month, observed annually in May by the patient and clinician communities, CGTLive® has decided to take a closer look at this ongoing clinical trial.

Data Roundup: April 2025 Features Updates for Cardiomyopathy Gene Therapy, Myasthenia Gravis CAR-T, and More

Data Roundup: April 2025 Features Updates for Cardiomyopathy Gene Therapy, Myasthenia Gravis CAR-T, and More

Noah Stansfield

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

Around the Helix: Cell and Gene Therapy Company Updates – April 30, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 30, 2025

Noah Stansfield

April 30th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – April 23, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 23, 2025

Noah Stansfield

April 23rd 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – April 16, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 16, 2025

Noah Stansfield

April 16th 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – April 9, 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 9, 2025

Noah Stansfield

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Alcon Scoops Up Aurion Biotech With Intent of Advancing Ophthalmology Cell Therapy AURN001

Alcon Scoops Up Aurion Biotech With Intent of Advancing Ophthalmology Cell Therapy AURN001

Alcon noted additional operational updates alongside the announcement.

1 2 3 4 5 6 7 8

...

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.